Table 2.
Expression of immune cell markers in FFPE tissue sections of treatment naïve (prim) or relapsed (relap) HNSCC patients.
| Lymphocyte infiltration | CD4 | CD8 | CD4/FoxP3 | NKp46 | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Intratumor | Peritumor | Intratumor | Peritumor | Intratumor | Peritumor | Intratumor | Peritumor | |||||||||
| Pr | Re | Pr | Re | Pr | Re | Pr | Re | Pr | Re | Pr | Re | Pr | Re | Pr | Re | |
| Total % positive | 68.0 | 50.0 | 72.5 | 66.7 | 70.0 | 60.0 | 64.7 | 44.4 | 73.5 | 75.0 | 67.3 | 62.5 | 36.5 | 33.3 | 46.2 | 44.4 |
| 0 (<1%) | 32.0 | 40.0 | 27.5 | 33.3 | 30.0 | 30.0 | 35.3 | 55.6 | 26.5 | 25.0 | 32.7 | 37.5 | 63.5 | 66.7 | 53.8 | 55.6 |
| I (1 – 5%) | 38.0 | 10.0 | 35.3 | 33.3 | 40.0 | 30.0 | 43.1 | 22.2 | 14.3 | 25.0 | 4.1 | 12.5 | 13.5 | 22.2 | 17.3 | 22.2 |
| II (6 – 10%) | 24.0 | 20.0 | 29.4 | 0.0 | 18.0 | 20.0 | 13.7 | 11.1 | 6.1 | 12.5 | 20.4 | 12.5 | 19.2 | 11.1 | 19.2 | 11.1 |
| III (>10%) | 6.0 | 20.0 | 7.8 | 33.3 | 12.0 | 10.0 | 7.8 | 11.1 | 53.1 | 37.5 | 42.9 | 37.5 | 3.8 | 0.0 | 9.6 | 11.1 |
| Average ratio with CD8 | 44.3 | 43.8 | 58.9 | 66.7 | – | – | – | – | 28.1 | 34.9 | 37.2 | 36.5 | – | – | – | – |
| TIME | ||||||||||||||||
| Pr | Re | |||||||||||||||
| Hot | 53.1 | 20.0 | ||||||||||||||
| Excluded | 6.1 | 30.0 | ||||||||||||||
| Deserted | 40.8 | 50.0 | ||||||||||||||
Pr, Primary; Re, Relapsed.